has entered into an agreement with Irish pharmaceutical company Allergan plc (NYSE: AGN) to co-promote Allergan's Bystolic
(nebivolol), a beta blocker approved for the treatment of hypertension to lower blood pressure, in the United States, the company said.
* Comment: In three monotherapy trials of more than 2,000 patients, and one combination therapy trial of almost 700 patients, the blood pressure-lowering effects of Bystolic
were in the high single digits, which is comparable with other [beta]-blockers, although not to the degree expected with a diuretic or calcium blocker, said Dr.
The FDA has approved Bystolic
(nebivolol) for the treatment of high blood pressure.
He also led the organization through the approval and launch of Bystolic
for hypertension and Campral for alcohol dependency.
In a review posted online, the agency said results from a company study of Bystolic
"lack robustness," and don't show a clear advantage for the drug.
) is a [beta]-blocker used for hypertension.
M2 PHARMA-April 3, 2012-Forest Laboratories Inc acquires Bystolic
Royalties from Janssen Pharmaceutica NV for USD357m(C)2012 M2 COMMUNICATIONS
M2 EQUITYBITES-November 12, 2010-Forest Laboratories Inc, Janssen Pharmaceutical NV and Janssen Pharmaceutical partners for Bystolic
and Savella in Canada(C)2010 M2 COMMUNICATIONS http://www.m2.com
Last year's figure included $455 million from its sale of rights to its blood pressure drug Bystolic
. Excluding that, revenue rose 5.2%.
maker of generic drugs, said profit rose 15% on the sale of rights to the blood pressure drug Bystolic
and on revenue from acquisitions.